Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES — Stella

Home/Lung Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Lung Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

Penn Medicine University City, Philadelphia, Pennsylvania

Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Penn Medicine Washington Square, Philadelphia, Pennsylvania

Key details

Sponsor

Abramson Cancer Center at Penn Medicine

Enrollment target

~300 participants

Started

January 2024

Primary completion

December 2026

Age range

35 Years – 89 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.